Trials Sponsors Conditions Drugs Pricing

Conditions

Ameloblastoma

Outcome Measures

Primary Outcomes (1)

Radiographic assessment CBCT
Radiographic assessment evaluate healing process CBCT (Planmeca Promax 3DMid machine, Helsinki Finland) scan will be obtained immediately post-operative ,3 and 6 months postoperative
From baseline to 3 and 6 months after the operation day

Study Arms (2)

Group A

ACTIVE COMPARATOR

About 7 patients who will be subjected to marsupialization procedure with a tetracycline socked pack during marsupialization

Drug: Tetracyclin

Group B

ACTIVE COMPARATOR

About 7 patients who will undergo conventional marsupialization procedure

Drug: Tetracyclin

Interventions

TetracyclinDrug

to evaluate the effect of tetracycline socked pack on acceleration of healing during marsupialization as a primary treatment for locally invasive lesions.

Also known as: marsupialization procedure

Group AGroup B

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age20 Years - 40 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64)

You may qualify if:

patients (class I category according to American society of anesthesiologists) over 20 years and under 40 years of age, of either gender who are seeking treatment of a painful intra-body mandibular swelling cystic lesions 3 x 4 cm in size with biopsy conformation that the lesion is a Uni-cystic ameloblastoma

You may not qualify if:

Sponsors & Collaborators

Minia University
Otherlead

Study Sites (1)

Faculty of Dentistry, Minia University

Minya, 2431412, Egypt

MeSH Terms

Conditions

Ameloblastoma

Interventions

Tetracycline

Condition Hierarchy (Ancestors)

Odontogenic TumorsNeoplasms by Histologic TypeNeoplasms

Intervention Hierarchy (Ancestors)

TetracyclinesNaphthacenesPolycyclic Aromatic HydrocarbonsHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic Chemicals

Study Officials

TAREK ABDELBARY, Lecturer
Faculty of Dentistry, Minia University
PRINCIPAL INVESTIGATOR

Enrollment

14 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: not applicable
Allocation: RANDOMIZED
Masking: DOUBLE
Who Masked: PARTICIPANT, INVESTIGATOR
Purpose: TREATMENT
Intervention Model: PARALLEL
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Lecturer of Oral and Maxillofacial Surgery

Study Record Dates

First Submitted

December 28, 2024

First Posted

January 6, 2025

Study Start

February 10, 2024

Actual (reported)

Effect of Tetracycline Socked Pack on Acceleration of Healing During Marsupialization

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Outcome Measures

Primary Outcomes (1)

Study Arms (2)

Group A

Group B

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

Study Completion

First Submitted

First Posted

Conditions

Outcome Measures

Primary Outcomes (1)

Study Arms (2)

Group A

Group B

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record

Locations